Table 2 The relation of high CA 15-3 concentration with the clinico-pathological variables analyzed.

Tumour size

   <2.5 cm

2/24(8.3%)

2/22(9.1%)

   >2.5 cm

22/24(91.6%)

0.627

20/22(90.9%)

0.884

Tumour histology

   Ductal

19/24(79.1%)

0.533

18/22(81.8%)

0.875

   Lobular

4/24(16.6%)

3/22(13.6%)

   Mixed

1/24(4.1%)

1/22(4.5%)

Tumour stage

   II

2/24(8.3%)

1/22(4.5%)

   III

20/24(83.3%)

0.266

20/22(90.9%)

0.256

   IV

2/24(8.3%)

1/22(4.5%)

Her2/neu positive

5/24 (20.8%)

0.487

5/22(22.7%)

1.000

ER positive

14/24(58.3%)

1.000

12/22(54.5%)

0.796

LVI

10/24(41.6%)

0.603

11/22(50%)

0.114